1. Frey N, Katus HA, Olson EN, Hill JA. Hypertrophy of the heart. Circulation 2004;109:1580‐9.
2. Camici PG, Crea F. Coronary microvascular dysfunction. N Engl J Med 2007;356:830‐40.
3. Camici PG, Tschöpe C, Di Carli MF, Rimoldi O, Van Linthout S. Coronary microvascular dysfunction in hypertrophy and heart failure. Cardiovasc Res 2020;116:806‐16.
4. Ommen SR, Mital S, Burke MA, Day SM, Deswal A, Elliott P. 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2020;142:e558‐631.
5. Authors TF, Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, et al. ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J 2014;2014:2733‐79.